CoChat

Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting

Open access
Julg, Boris, Dee, Lynda, Ananworanich, Jintanat, Barouch, Dan H, Bar, Katharine, Caskey, Marina, Colby, Donn J, Dawson, Liza, Dong, Krista L, Dubé, Karine, Eron, Joseph, Frater, John, Gandhi, Rajesh T, Geleziunas, Romas, Goulder, Philip, Hanna, George J, Jefferys, Richard, Johnston, Rowena, Kuritzkes, Daniel, Li, Jonathan Z, Likhitwonnawut, Udom, van Lunzen, Jan, Martinez-Picado, Javier, Miller, Veronica, Montaner, Luis J, Nixon, Douglas F, Palm, David, Pantaleo, Giuseppe, Peay, Holly, Persaud, Deborah, Salzwedel, Jessica, Salzwedel, Karl, Schacker, Timothy, Sheikh, Virginia, Søgaard, Ole S., Spudich, Serena, Stephenson, Kathryn, Sugarman, Jeremy, Taylor, Jeff, Tebas, Pablo, Tiemessen, Caroline T, Tressler, Randall, Weiss, Carol D, Zheng, Lu, Robb, Merlin L, Michael, Nelson L, Mellors, John W, Deeks, Steven G, Walker, Bruce D · 2019 · The Lancet HIV
Cited by 204

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Summary: Analytical antiretroviral treatment interruption (ATI) is an important feature of HIV research seeking to achieve sustained viral suppression in the absence of antiretroviral therapy (ART) when the goal is to measure effects of novel therapeutic interventions on time to viral load rebound, post ART control, and/or altered set-point. Trials with ATIs also intend to determine host, virologic and immunologic markers predictive of sustained viral control off ART. Although ATI is increasingly incorporated into proof-of-concept trials, there is no consensus on strategies to maximize its utility and minimize its risks. In addition, differences in ATI trial designs hinder the ability to compare efficacy and safety of interventions across trials. Therefore, we held a meeting of stakeholders from many interest groups, including scientists, clinicians, ethicists, social scientists, regulators, people living with HIV and advocacy groups to discuss the main challenges concerning ATI studies and to formulate recommendations with an emphasis on strategies for risk mitigation and monitoring, ART resumption criteria and ethical considerations. In this report we present the major points of discussion and consensus views achieved with the goal of informing the conduct of ATIs to maximize the knowledge gained and minimize the risk to participants in clinical HIV research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2352-3018(19)30052-9

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Prospective study of acute HIV-1 infection in adults in East Africa and Thailand.

    Robb, M. L., Eller, L. A., Kibuuka, H., Rono, K., Maganga, L., Nitayaphan, S., Kroon, E., Sawe, F. K., Sinei, S., Sriplienchan, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1508952 · Cited by 283 · cited 2×

    “Specific clinical signs and symptoms that raise concern for ARS include malaise, fever, headache, lymphadenopathy, rash, sore throat, myalgia/arthralgia, unintentional weight loss, night sweats and diarrhea (29, 30).”
    BackgroundMethodSelf-citation

Show all 1 references

Cited by

See all 204

Metadata

Authors
Julg, B., Dee, L., Ananworanich, J., Barouch, D. H., Bar, K., Caskey, M., Colby, D. J., Dawson, L., Dong, K. L., Dubé, K., Eron, J., Frater, J., Gandhi, R. T., Geleziunas, R., Goulder, P., Hanna, G. J., Jefferys, R., Johnston, R., Kuritzkes, D., Li, J. Z., Likhitwonnawut, U., van Lunzen, J., Martinez-Picado, J., Miller, V., Montaner, L. J., Nixon, D. F., Palm, D., Pantaleo, G., Peay, H., Persaud, D., Salzwedel, J., Salzwedel, K., Schacker, T., Sheikh, V., Søgaard, O. S., Spudich, S., Stephenson, K., Sugarman, J., Taylor, J., Tebas, P., Tiemessen, C. T., Tressler, R., Weiss, C. D., Zheng, L., Robb, M. L., Michael, N. L., Mellors, J. W., Deeks, S. G., & Walker, B. D.
Venue
The Lancet HIV
Publisher
Elsevier BV
Published
2019-04
Volume
6
Issue
4
Pages
e259-e268
ISSN
2352-3018 (ISSN-L)
OpenAlex
W2921307991
Cited by
204
References
1
FWCI
15.17
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting. https://app.cochat.ai/papers/10.1016/s2352-3018(19)30052-9
The paper
Julg, B., Dee, L., Ananworanich, J., Barouch, D. H., Bar, K., Caskey, M., Colby, D. J., Dawson, L., Dong, K. L., Dubé, K., Eron, J., Frater, J., Gandhi, R. T., Geleziunas, R., Goulder, P., Hanna, G. J., Jefferys, R., Johnston, R., Kuritzkes, D., . . . Walker, B. D. (2019). Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting. The Lancet HIV. https://doi.org/10.1016/s2352-3018(19)30052-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.